Trial intelligence / Profile preview

Milk Thistle for Pediatric NAFLD

NCT06477146Phase 2Recruiting

Sponsor
University Hospitals Cleveland Medical Center
Start
Dec 2024
Primary completion
Jan 2029
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of silybum marianum extract in non-alcoholic fatty liver disease (NAFLD), sponsored by University Hospitals Cleveland Medical Center. Started Dec 2024; status: recruiting.

02

Drugs

silybum marianum extract
03

Conditions

non-alcoholic fatty liver disease (NAFLD)

Beyond the preview

Go deeper on NCT06477146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06477146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call